ImmunoPrecise Antibodies shares rise 7.25% premarket after announcing participation in H.C. Wainwright Global Investment Conference.

miércoles, 3 de septiembre de 2025, 6:29 am ET1 min de lectura
IPA--
ImmunoPrecise Antibodies Ltd. rose 7.25% in premarket trading, with the company announcing its participation in the 27th Annual H.C. Wainwright Global Investment Conference. Dr. Jennifer Bath, President and CEO of IPA, will deliver a company presentation and be available for one-on-one investor meetings throughout the event.

ImmunoPrecise Antibodies shares rise 7.25% premarket after announcing participation in H.C. Wainwright Global Investment Conference.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios